Anna Vaharautio
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Decoding the epigenetics of persister states in ovarian cancer.
Journal: Cell reports
Published: November 21, 2025
Drug target proteome profiling identifies HES1-driven mitotic catastrophe in ovarian serous carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 10, 2025
Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes.
Journal: Cancer discovery
Published: August 27, 2025
Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.
Journal: Cancer discovery
Published: August 27, 2025
Ex Vivo Immuno-Oncology Platform Reveals Spatial T-cell Infiltration Patterns Linked to ATR Inhibition Responses in High-Grade Serous Ovarian Cancer.
Journal: Cancer immunology research
Published: June 18, 2025
Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer.
Journal: Cancer discovery
Published: April 14, 2025
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer.
Journal: Cell reports. Medicine
Published: February 03, 2025
Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer.
Journal: Cancer research
Published: November 25, 2024
Single-Cell Lineage Tracing Uncovers Resistance Signatures and Sensitizing Strategies to FLT3 Inhibitors in Acute Myeloid Leukemia.
Journal: Cancer research
Published: October 10, 2024
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer.
Journal: bioRxiv : the preprint server for biology
Published: April 02, 2024
Last Updated: 09/26/2026